Biobetters a big opportunity for biopharm and CROs
Biobetters, more than biosimilars, are the big opportunity for biopharm and CROs hoping to profit from biologics patent expirations, say experts.
Archives for April 11, 2011
EMD Millipore talks single use technology at Interphex 2011
How have single-use technologies changed drug production? How do you dispose of a disposable technology? What will drive the market going forward? EMD Millipore answered these questions and more at Interphex 2011.